Company Profile
Hoffmann-La Roche Inc. is a multinational pharmaceutical company headquartered in Basel, Switzerland. Founded in 1896, it has grown into one of the world's leading pharmaceutical companies, renowned for its rich portfolio of innovative medicines and diagnostics.
Hoffmann-La Roche operates globally with a strong presence in more than 100 countries around the world. The company's broad portfolio covers multiple therapeutic areas such as oncology, diabetes and mental health. In addition to pharmaceuticals, Hoffmann-La Roche also develops diagnostic products such as reagents and instruments for research and clinical testing.
Hoffmann-La Roche's R&D strategy is focused on the discovery and development of novel biopharmaceuticals to address unmet medical needs and improve patient outcomes. The company's research facilities are located in Switzerland and the United States and focus on developing novel treatments for cancer, diabetes and other chronic diseases.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
ribavirin |
1H-1,2,4-Triazole-3-carboxamide,1-β-D-ribofuranosyl-;1-β-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide;Virazole;1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide;ICN 1229;Ribavirin;Viramid;1-β-D-Ribofuranosyl-1,2,4-triazol-3-carboxyamide;NSC 163039;Vilona;Ribamide;Ribamidil;Tribavirin;Rebetol;Ribavarin;Ravanex;Copegus;Ribasphere;Virizadole;MegaRibavirin;EBP 954;Meduna;Virin;1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide;Cotronak;66510-90-5;437710-49-1 |
36791-04-5 | Inquiry |